TC
VIVO

TFS Capital’s Meridian Bioscience Inc VIVO Stock Holding History

TFS Capital’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-38,240
Closed -$730K – 1135
2015
Q1 		$730K Buy
+38,240
New +$707K 0.07% 430

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TFS Capital's VIVO Position: Q2 2015 in Review

TFS Capital sold out of Meridian Bioscience Inc (VIVO) in Q2 2015, closing a stake of 38,240 shares — an estimated $730K sold.

TFS Capital first reported a position in VIVO in Q1 2015 and held it in 1 quarter. The position peaked at $730K in Q1 2015. 167 funds tracked by Wall St. Rank hold VIVO as of Q2 2015.

  • TFS Capital reported no remaining Meridian Bioscience Inc position as of Q2 2015 after selling out during the quarter.
  • TFS Capital sold 38,240 Meridian Bioscience Inc shares in Q2 2015, an estimated $730K.
  • TFS Capital first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 1 quarter.
  • TFS Capital's Meridian Bioscience Inc position peaked at $730K in Q1 2015.
  • 167 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2015.

Based on TFS Capital's 13F filing for Q2 2015, filed 5 Aug 2015.